Linda M Rubinstein's Net Worth

$648 Thousand

Estimate Recalculated Mar 21, 2024 04:04PM EST

Who is Linda M Rubinstein?

Linda M Rubinstein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alector, Inc., BIOCEPT INC, Adverum Biotechnologies, Inc., FIVE PRIME THERAPEUTICS INC, and Solexa, Inc..

SEC CIK

Linda M Rubinstein's CIK is 0001321937

Past Insider Trading and Trends

2006 was Linda M Rubinstein's most active year for acquiring shares with 8 total transactions. Linda M Rubinstein's most active month to acquire stocks was the month of November. 2006 was Linda M Rubinstein's most active year for disposing of shares, totalling 14 transactions. Linda M Rubinstein's most active month to dispose stocks was the month of November. 2005 saw Linda M Rubinstein paying a total of $1,010,760.00 for 166,000 shares, this is the most they've acquired in one year. In 2006 Linda M Rubinstein cashed out on 179,998 shares for a total of $2,280,941.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alector, Inc. (ALEC) Snapshot price: $6.41

Interim Chief Financial Ofcr

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

BIOCEPT INC (BIOCQ) Snapshot price: $0.005

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 8
Form 4
—
0
—
—
0
Jul 16
Form 3
—
0
—
—
0
No matching records found

Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $2.4

CHIEF FINANCIAL OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Aug 3
Form 4
∞
100K
$1.45
$145,490.00
100K
Jun 7
Form 3
—
0
—
—
0
No matching records found

FIVE PRIME THERAPEUTICS INC No price found

Interim CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Solexa, Inc. No price found

VP and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
$10.06
-$97,072.40
0
Dec 14 - Dec 15
Form 4
—
0
$9.48
-$456,785.62
0
Dec 13
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Sep 6
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found